Brief: IN8bio Announces New Preclinical Data For Gamma-Delta nsCAR-T Cell Therapy Platform At AACR 2024
09/04/2024 22:24
April 9 (Reuters) - IN8bio, Inc. INAB.O :
* IN8BIO ANNOUNCES NEW PRECLINICAL DATA FOR GAMMA-DELTA
NSCAR-T
CELL THERAPY PLATFORM AT AACR 2024
Source text for Eikon: ID:nGNX2FrC7p
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall